About this trial
To evaluate the role of Double Inversion Recovery (DIR) and Diffusion Tensor Imaging (DTI) in the assessment of optic neuritis and to correlate imaging findings with clinical and visual outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age above 18 years.
Clinically suspected optic neuritis.
Evidence of multiple sclerosis or other demyelinating diseases.
Disqualifiers
Traumatic optic neuritis.
Systemic diseases affecting the optic nerve.
Contraindications to MRI.
Trial population
Adults with clinically suspected optic neuritis referred for MRI evaluation, together with healthy control participants.
Trial design
Case-control
Prospective
Treatments tested in this trial
MRI
DeviceDTI and DIR
Treatment groups
Trial outcomes
Primary outcomes
Fractional anisotropy (FA) value of the affected optic nerve measured by diffusion tensor imaging (DTI)
Fractional anisotropy (FA) values will be calculated from regions of interest placed along the affected optic nerve and compared between participants with optic neuritis and healthy controls.
Mean diffusivity (MD) value of the affected optic nerve measured by diffusion tensor imaging (DTI)
Mean diffusivity (MD) values will be calculated from regions of interest placed along the affected optic nerve and compared between participants with optic neuritis and healthy controls.
Secondary outcomes
Number of optic nerve lesions detected using Double Inversion Recovery MRI.
The number of optic nerve lesions identified on DIR images will be recorded for each participant.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: